) and incorporated into these prognostic programs, but none of these tries succeeded in getting to be standard of care.94–ninety six In fact, the Global Workshop on CLL (iwCLL) recommendations only advocate evaluating the IGHV status and presence/absence of TP53 aberrations in regime practice.).82,eighty three Clients with MBL with mutated driver